phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Chen, Z; Li, D; Ma, X; Qian, A; Shang, P; Sun, Y | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Neuropeptide FF attenuates RANKL-induced differentiation of macrophage-like cells into osteoclast-like cells.
Topics: Acid Phosphatase; Bone Resorption; Cell Differentiation; Cell Line; Cells, Cultured; Down-Regulation; Isoenzymes; Macrophages; Oligopeptides; Osteoclasts; RANK Ligand; Real-Time Polymerase Chain Reaction; Tartrate-Resistant Acid Phosphatase | 2015 |